Novavax Inc
Current role
NVAX
Ruxandra Draghia-Akli
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Ruxandra Draghia-Akli
The proxy statement of Novavax Inc reports total compensation of $2,303,380 for Ruxandra Draghia-Akli in fiscal 2025, including a base salary of $600,000.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Novavax Inc (NVAX)
Source not stated
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Novavax Inc
Other people whose current roles at this company are on record from its filings.
- John C. Jacobs CEO, Board Member
- Gregory F. Covino CFO
- James P. Kelly CFO
- John J. Trizzino CFO, COO
- John Trizzino CFO
- Mark Casey General Counsel
- Charles W. Newton Board Member
- David M. Mott Board Member
- David Mott Board Member
- Gregg H. Alton Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Novavax Inc (NVAX) | M.D., Ph.D. Former EVP, Head of Research & Development | $600,000 | $2,303,380 |
Recent activity
No call appearances or filed executive changes recorded yet.